Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
Website: | www.herontx.com |
Email: | info@herontx.com |
Main Phone: | +1 650 366-2626 |
Address: | 123 Saginaw Drive |
State: | CA |
City / Town: | Redwood City |
Country: | USA |
Postal Code: | 94063 |
Exchange: | NSC |
Employees: | 148 |
NAICS: | Pharmaceutical P |
Last Price 31.15 | Change $ 1.30 | Change % 4.36 | Tick N/A |
Bid 29.80 | Bid Size 500.00 | Ask 31.10 | Ask Size 100.00 |
Open 29.85 | High 31.35 | Low 29.85 | Prev Close 29.85 |
Last Trade | Volume 1.1 mi | 52 Wk Hi 32.70 | 52 Wk Low 12.70 |
Market Cap 2.2 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares 70,648,383.00 | EPS (TTM) -3.67 | PE Ratio N/A | Exchange NCM |
|
|
Last 3 Mo | Last 12 Mo | |
---|---|---|
Number of Insider Trades | 6 | 23 |
Number of Buys | 3 | 14 |
Number of Sells | 3 | 9 |
Net Activity | 1010991 | 1044835 |
Last 10 Buys | Shares |
---|---|
Kevin C. Tang | 1,000 |
Kevin C. Tang | 1,000 |
Kevin C. Tang | 1,000 |
Kevin C. Tang | 1,000 |
Kevin C. Tang | 1,000 |
Barry D. Quart | 1,000 |
Barry D. Quart | 1,000 |
Kevin C. Tang | 1,000 |
Last 10 Sell | Shares |
---|---|
Robert H. Rosen | 1,000 |
Robert H. Rosen | 1,000 |
Robert H. Rosen | 1,000 |
Robert H. Rosen | 1,000 |
Robert H. Rosen | 1,000 |
Robert H. Rosen | 1,000 |
Robert H. Rosen | 1,000 |
Robert H. Rosen | 1,000 |
Kimberly J. Manhard | 1,000 |
Kimberly J. Manhard | 1,000 |
Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
---|---|---|---|---|
High Target Price Estimate | 55 | 55 | 55 | 55 |
Low Target Price Estimate | 33 | 38 | 38 | 33 |
Mean Target Price Estimate | 43.75 | 45.13 | 46 | 43.75 |
Standard Deviation | 7.01 | 6.03 | 5.32 | 7.01 |
Date of Most Recent Estimate | 08/11/16 | 08/01/16 | 07/11/16 | 08/19/16 |
Form Type | Form Description | Pages | Date |
---|---|---|---|
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-08-12 |
SC 13D/A | Amendment to a SC 13D filing | 8 | 2016-08-10 |
8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-08-10 |
8-K | Report of unscheduled material events or corporate changes. | 20 | 2016-08-10 |
10-Q | Quarterly report with a continuing view of a company's financial position | 57 | 2016-08-08 |
8-K | Report of unscheduled material events or corporate changes. | 8 | 2016-08-08 |
8-K | Report of unscheduled material events or corporate changes. | 45 | 2016-08-01 |
S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | 30 | 2016-07-29 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-20 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-23 |
Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Strong Buy | 8 | 8 | 9 | 9 |
Moderate Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Moderate Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Mean Rec. | 1 | 1 | 1 | 1 |